Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 33.25
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Excellent dividends
Data is available to registered users only
Data is available to registered users only
About
Level Biotechnology Inc. engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan. It also markets and distributes biomedical precision equipment. In addition, the company provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production. Further, it offers preclinical research services to the biotech, pharmaceutical,...
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITD.
Data is available to registered users only
Buy
Sell